SCHEMBL19979477

SCHEMBL19979477

CCCCCCCCCc1ccc(Nc2cccc(OC)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 5/20 0.55
MTNR1A P48039 3/20 0.55
KMT2A Q03164 6/20 0.53
MEN1 O00255 5/20 0.53
MAPT P10636 4/20 0.53
ALDH1A1 P00352 2/20 0.53
GAA P10253 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MAPK1 P28482 2/20 0.53
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.53
ALOX12 P18054 1/20 0.53
PLK1 P53350 2/20 0.50
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
PLK3 Q9H4B4 1/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1423027 0.87 UNG (0.54) ALDH1A1LMNA
SCHEMBL19984884 0.82 ALDH1A1 (0.48) MTNR1BMTNR1AKMT2AMEN1MAPT
SCHEMBL7651565 0.81 NPSR1 (0.54) KMT2AMEN1ALDH1A1GAALMNA
SCHEMBL856119 0.81 MAPT (0.62) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL9274463 0.80 HPGD (0.50) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL27480376 0.80 HTR2A (0.54) ALDH1A1LMNAPLK1
SCHEMBL21634393 0.80 HTR2A (0.54) ALDH1A1LMNAPLK1
SCHEMBL11204938 0.80 HTR2A (0.54) ALDH1A1LMNAPLK1
SCHEMBL449939 0.80 HTR2A (0.54) ALDH1A1LMNAPLK1
SCHEMBL2493792 0.80 HTR2A (0.54) ALDH1A1LMNAPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS LANXESS CORPORATION 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS GPX4, CAT, SOD1 MTNR1B 477/4885MTNR1A 315/4885KMT2A 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.